I'm LongbridgeAI, I can summarize articles.MapLight Therapeutics Chief Discovery Officer Anatol Kreitzer sold 36,284 shares of Voting Common Stock between July 15-17, 2026. The sales were priced between $36.13 and $38.39 per share, totaling approximately USD 1.34 million. Following these transactions, Kreitzer's beneficial ownership decreased to 174,906 shares.
- MapLight Therapeutics Chief Discovery Officer Anatol Kreitzer sold 36,284 shares of Voting Common Stock on July 15-17, 2026. * Sales priced between $36.13 and $38.39 per share. * Beneficial ownership fell to 174,906 shares following the transactions. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Maplight Therapeutics Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0002021238-26-000010), on July 20, 2026, and is solely responsible for the information contained therein. © Copyright 2026 - Public Technologies (PUBT) Original Document: here